Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for acute myeloid leukemia with BCR-ABL1 has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy and biologic therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
103 publications have been identified in PubMed for acute myeloid leukemia with BCR-ABL1. Research spans Case Report / Case Series (33%), Review / Meta-Analysis (18%), and Clinical Trial Publication (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 33 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 6:51 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about acute myeloid leukemia with BCR-ABL1
Research summaries | 18 | 18% |
Clinical study results | 13 | 13% |
Laboratory research | 13 | 13% |
Testing and diagnosis research | 9 | 9% |
Disease patterns and progression | 9 | 9% |
New treatment approaches | 3 | 3% |
Other research | 2 | 2% |
Omar MMA (2026). [PMID: 42074261](https://pubmed.ncbi.nlm.nih.gov/42074261/). *Int J Mol Sci*. [Basic Science / Preclinical]
Mohty R (2026). [PMID: 41954351](https://pubmed.ncbi.nlm.nih.gov/41954351/). *Leuk Lymphoma*. [Basic Science / Preclinical]
Obeagu EI (2026). [PMID: 41675902](https://pubmed.ncbi.nlm.nih.gov/41675902/). *Ann Med Surg (Lond)*. [Review / Meta-Analysis]
Gravenmier C (2026). [PMID: 41295979](https://pubmed.ncbi.nlm.nih.gov/41295979/). *Cancer Res Commun*. [Diagnostic / Biomarker]
Alonso-Dominguez JM (2026). [PMID: 41960747](https://pubmed.ncbi.nlm.nih.gov/41960747/). *Cancer*. [Epidemiology / Natural History]
Wang F (2026). [PMID: 42103678](https://pubmed.ncbi.nlm.nih.gov/42103678/). *Zhonghua Yi Xue Za Zhi*. [Basic Science / Preclinical]
Yang W (2026). [PMID: 41483382](https://pubmed.ncbi.nlm.nih.gov/41483382/). *Discov Oncol*. [Basic Science / Preclinical]
Sayyada A (2026). [PMID: 41522563](https://pubmed.ncbi.nlm.nih.gov/41522563/). *Indian J Hematol Blood Transfus*. [Gene Therapy / Novel Therapeutics]
Cruz-Rodriguez N (2026). [PMID: 41676916](https://pubmed.ncbi.nlm.nih.gov/41676916/). *Haematologica*. [Diagnostic / Biomarker]
Kong C (2026). [PMID: 41981865](https://pubmed.ncbi.nlm.nih.gov/41981865/). *Angew Chem Int Ed Engl*. [Basic Science / Preclinical]